726 related articles for article (PubMed ID: 18313224)
1. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.
Gupta K; Miller JD; Li JZ; Russell MW; Charbonneau C
Cancer Treat Rev; 2008 May; 34(3):193-205. PubMed ID: 18313224
[TBL] [Abstract][Full Text] [Related]
2. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
3. EORTC-GU group expert opinion on metastatic renal cell cancer.
de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
[TBL] [Abstract][Full Text] [Related]
4. Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.
Vrdoljak E; Ciuleanu T; Kharkevich G; Mardiak J; Mego M; Padrik P; Petruželka L; Purkalne G; Shparyk Y; Skrbinc B; Szczylik C; Torday L
Expert Opin Pharmacother; 2012 Feb; 13(2):159-74. PubMed ID: 22195646
[TBL] [Abstract][Full Text] [Related]
5. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.
Halbert RJ; Figlin RA; Atkins MB; Bernal M; Hutson TE; Uzzo RG; Bukowski RM; Khan KD; Wood CG; Dubois RW
Cancer; 2006 Nov; 107(10):2375-83. PubMed ID: 17048248
[TBL] [Abstract][Full Text] [Related]
6. Patient-based strategy for systemic treatment of metastatic renal cell carcinoma.
Kirchner H; Strumberg D; Bahl A; Overkamp F
Expert Rev Anticancer Ther; 2010 Apr; 10(4):585-96. PubMed ID: 20397923
[TBL] [Abstract][Full Text] [Related]
7. Economic burden of adverse events in patients with metastatic renal cell carcinoma.
Hagiwara M; Borker R; Oster G
Clin Ther; 2013 Dec; 35(12):1955-1963.e2. PubMed ID: 24290735
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic renal cell carcinoma.
Reeves DJ; Liu CY
Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of renal cell cancer.
Cho E; Adami HO; Lindblad P
Hematol Oncol Clin North Am; 2011 Aug; 25(4):651-65. PubMed ID: 21763961
[TBL] [Abstract][Full Text] [Related]
10. Review of potential risk factors for kidney (renal cell) cancer.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):280-93. PubMed ID: 11769880
[TBL] [Abstract][Full Text] [Related]
11. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
Harshman LC; Srinivas S
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749
[TBL] [Abstract][Full Text] [Related]
12. Rising incidence of small renal masses: a need to reassess treatment effect.
Hollingsworth JM; Miller DC; Daignault S; Hollenbeck BK
J Natl Cancer Inst; 2006 Sep; 98(18):1331-4. PubMed ID: 16985252
[TBL] [Abstract][Full Text] [Related]
13. Elicitation of health state utilities in metastatic renal cell carcinoma.
Swinburn P; Lloyd A; Nathan P; Choueiri TK; Cella D; Neary MP
Curr Med Res Opin; 2010 May; 26(5):1091-6. PubMed ID: 20225993
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic aspects of renal cell cancer.
McLaughlin JK; Lipworth L
Semin Oncol; 2000 Apr; 27(2):115-23. PubMed ID: 10768591
[TBL] [Abstract][Full Text] [Related]
15. Kidney cancer.
Wallen EM; Pruthi RS; Joyce GF; Wise M;
J Urol; 2007 Jun; 177(6):2006-18; discussion 2018-9. PubMed ID: 17509280
[TBL] [Abstract][Full Text] [Related]
16. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
[TBL] [Abstract][Full Text] [Related]
17. Update on the medical treatment of metastatic renal cell carcinoma.
Ravaud A; Wallerand H; Culine S; Bernhard JC; Fergelot P; Bensalah K; Patard JJ
Eur Urol; 2008 Aug; 54(2):315-25. PubMed ID: 18485581
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, clinical staging, and presentation of renal cell carcinoma.
Decastro GJ; McKiernan JM
Urol Clin North Am; 2008 Nov; 35(4):581-92; vi. PubMed ID: 18992612
[TBL] [Abstract][Full Text] [Related]
19. Kidney cancer: the new landscape.
Linehan JA; Nguyen MM
Curr Opin Urol; 2009 Mar; 19(2):133-7. PubMed ID: 19188766
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic aspects of renal cell carcinoma.
McLaughlin JK; Lipworth L; Tarone RE
Semin Oncol; 2006 Oct; 33(5):527-33. PubMed ID: 17045081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
